The Journal of
Clinical Psychiatry

Volume 64 • 2003 • 9

Brainstorms

Deconstructing Psychiatric Disorders, Part 1: Genotypes, Symptom Phenotypes, and Endophenotypes

J Clin Psychiatry 2003;64(9):982-983

Stephen M. Stahl, MD, PhD

Original Research

Polypharmacy in Patients With Schizophrenia

J Clin Psychiatry 2003;64(9):984-989

Robert E. McCue, MD ; Rubina Waheed, MD ; Leonel Urcuyo, MD

Original Research

Depersonalization Disorder Update | Psychiatrist.com

J Clin Psychiatry 2003;64(9):990-997

Daphne Simeon, MD ; Margaret Knutelska, MPh ; Dorothy Nelson, BSc ; Orna Guralnik, PsyD

Original Research

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

J Clin Psychiatry 2003;64(9):998-1004

Peter D. Feldman, PhD ; Christopher J. Kaiser, PhD ; John S. Kennedy, MD ; Virginia K. Sutton, PhD ; Pierre V. Tran, MD ; Gary D. Tollefson, MD, PhD ; Fan Zhang, PhD ; Alan Breier, MD

Original Research

Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients.

J Clin Psychiatry 2003;64(9):1005-1012

Sabine Kubesch, MA ; Volker Bretschneider, MA ; Roland Freudenmann, MD ; Niels Weidenhammer, MA ; Manfred Lehmann, MD ; Manfred Spitzer, MD, PhD ; Georg Grön, PhD

Original Research

A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder

J Clin Psychiatry 2003;64(9):1013-1024

Joseph R. Calabrese, MD ; Charles L. Bowden, MD ; Gary Sachs, MD ; Lakshmi N. Yatham, MBBR,FRCPC, MRCPsych ; Kirsten Behnke, MD ; Olli-Pekka Mehtonen, MD ; Paul Montgomery, PharmD ; John Ascher, MD ; Walter Paska, PhD ; Nancy Earl, MD ; Joseph DeVeaugh-Geiss, MD

Original Research

Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder

J Clin Psychiatry 2003;64(9):1025-1030

William A. Hewlett, MD, PhD ; Sabine P. Schmid, MA ; Ronald M. Salomon, MD

Original Research

Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling

J Clin Psychiatry 2003;64(9):1031-1038

Otto Kausch, MD

Original Research

A 3-Year Naturalistic Study of 53 Preschool Children With Pervasive Developmental Disorders Treated With Risperidone

J Clin Psychiatry 2003;64(9):1039-1047

Gabriele Masi, MD ; Angela Cosenza, MD ; Maria Mucci, MD ; Paola Brovedani, PhD

Original Research

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia: A Placebo-Controlled 26-Week Study

J Clin Psychiatry 2003;64(9):1048-1056

Teresa A. Pigott, MD ; William H. Carson, MD ; Anutosh R. Saha, PhD ; Anne F. Torbeyns, PhD ; Elyse G. Stock, MD ; Gary G. Ingenito, MD^{Aripiprazole Study Group}

Original Research

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study

J Clin Psychiatry 2003;64(9):1057-1064

Charles DeBattista, MD ; Karl Doghramji, MD ; Matthew A. Menza, MD ; Murray H. Rosenthal, DO ; Ronald R. Fieve, Md^{Modafinil in Depression Study Group}

Original Research

Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression

J Clin Psychiatry 2003;64(9):1065-1074

Mark Hyman Rapaport, MD ; Lon S. Schneider, MD ; David L. Dunner, MD ; John T. Davies, MSc ; Cornelius D. Pitts, RPh

Original Research

Incidence of Tardive Dyskinesia in First-Episode Psychosis Patients Treated With Low-Dose Haloperidol

J Clin Psychiatry 2003;64(9):1075-1080

Piet P. Oosthuizen, MB ; Robin A. Emsley, MD ; J. Stephanus Maritz, DSc ; Jadri A. Turner, MB ; N. Keyter, RN

Original Research

Treatment of Previously Undiagnosed Psychiatric Disorders in Persons With Developmental Disabilities Decreased or Eliminated Self-Injurious Behavior

J Clin Psychiatry 2003;64(9):1081-1090

John A. Tsiouris, MD ; Ira L. Cohen, PhD ; Paul J. Patti, MA ; William M. Korosh, PhD

Original Research

How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial?

J Clin Psychiatry 2003;64(9):1091-1093

Gabor I. Keitner, MD ; Michael A. Posternak, MD ; Christine E. Ryan, PhD

Original Research

Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder

J Clin Psychiatry 2003;64(9):1094-1100

T. Petteri Sokero, MD ; Tarja K. Melartin, MD ; Heikki J. Rytsälä, MD ; Ulla S. Leskelä, MA ; Paula S. Lestelä-Mielonen, MA ; Erkki T. Isometsä, MD, PhD

Original Research

Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement

J Clin Psychiatry 2003;64(9):1101-1105

Francesc Colom, PsyD, MSc, PhD ; Eduard Vieta, MD, PhD ; María Reinares, PsyD, PhD ; Anabel Martínez-Arán, PsyD, PhD ; Carla Torrent, PsyD, PyD ; José Manuel Goikolea, MD ; Cristóbal Gastó, MD, PhD

Original Research

The Use of Atypical Antipsychotics in Nursing Homes

J Clin Psychiatry 2003;64(9):1106-1112

Rosa Liperoti, MD ; Vincent Mor, PhD ; Kate L. Lapane, PhD ; Claudio Pedone, MD, PhD, MPH ; Giovanni Gambassi, MD ; Roberto Bernabei, MD

Original Research

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

J Clin Psychiatry 2003;64(9):1113-1121

Eric Hollander, MD^{for the Paroxetine OCD Study Group} ; Andrea Allen, PhD ; Martin Steiner, PhD ; David E. Wheadon, MD ; Rosemary Oakes, MS ; Daniel B. Burnham, PhD

Academic Highlights

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders.

J Clin Psychiatry 2003;64(9):1122-1129

Letter to the Editor

Underdiagnosis of Bipolar II Disorders in the Community

J Clin Psychiatry 2003;64(9):1130-1131

Franco Benazzi, MD

Letter to the Editor

Charles Bonnet Syndrome With Visual Hallucinations of Childhood Experience: Successful Treatment of 1 Patient With Risperidone

J Clin Psychiatry 2003;64(9):1131-1132

Kazuhisa Maeda ; Yukihiko Shirayama ; Shu Nukina ; Shinichi Yoshioka ; Ryuzo Kawahara

Letter to the Editor

Polypharmacy in Schizophrenia: A Fuzzy Concept

J Clin Psychiatry 2003;64(9):1132-1132

Oliver Freudenreich ; Donald C. Goff

Letter to the Editor

Reply to Polypharmacy in Schizophrenia: A Fuzzy Concept

J Clin Psychiatry 2003;64(9):1132-1132

Stephen M. Stahl

Letter to the Editor

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

J Clin Psychiatry 2003;64(9):1133-1134

Deanna L. Kelly ; Julie Kreyenbuhl ; Raymond C. Love ; Quynh Van-Duong ; Robert R. Conley

Book Review

Core Competencies for Psychiatric Practice: What Clinicians Need to Know ( A Report of the American Board of Psychiatry and Neurology)

J Clin Psychiatry 2003;64(9):1135-1335

Book Review

Infanticide: Psychosocial and Legal Perspectives on Mothers Who Kill

J Clin Psychiatry 2003;64(9):1135-1136

Book Review

Outcomes in Neurodevelopment and Genetic Disorders

J Clin Psychiatry 2003;64(9):1136-1136

Volume 64 • 2003 • 9

Brainstorms

Deconstructing Psychiatric Disorders, Part 1: Genotypes, Symptom Phenotypes, and Endophenotypes

Original Research

Polypharmacy in Patients With Schizophrenia

Depersonalization Disorder Update | Psychiatrist.com

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients.

A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder

Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder

Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling

A 3-Year Naturalistic Study of 53 Preschool Children With Pervasive Developmental Disorders Treated With Risperidone

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia: A Placebo-Controlled 26-Week Study

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study

Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression

Incidence of Tardive Dyskinesia in First-Episode Psychosis Patients Treated With Low-Dose Haloperidol

Treatment of Previously Undiagnosed Psychiatric Disorders in Persons With Developmental Disabilities Decreased or Eliminated Self-Injurious Behavior

How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial?

Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder

Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement

The Use of Atypical Antipsychotics in Nursing Homes

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

Academic Highlights

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders.

Letter to the Editor

Underdiagnosis of Bipolar II Disorders in the Community

Charles Bonnet Syndrome With Visual Hallucinations of Childhood Experience: Successful Treatment of 1 Patient With Risperidone

Polypharmacy in Schizophrenia: A Fuzzy Concept

Reply to Polypharmacy in Schizophrenia: A Fuzzy Concept

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

Book Review

Core Competencies for Psychiatric Practice: What Clinicians Need to Know ( A Report of the American Board of Psychiatry and Neurology)

Infanticide: Psychosocial and Legal Perspectives on Mothers Who Kill

Outcomes in Neurodevelopment and Genetic Disorders

ELSEWHERE:

FOLLOW US:

Volume 64 • 2003 • 9

Brainstorms

Deconstructing Psychiatric Disorders, Part 1: Genotypes, Symptom Phenotypes, and Endophenotypes

Original Research

Polypharmacy in Patients With Schizophrenia

Depersonalization Disorder Update | Psychiatrist.com

Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years

Aerobic Endurance Exercise Improves Executive Functions in Depressed Patients.

A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder

Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder

Suicide Attempts Among Veterans Seeking Treatment for Pathological Gambling

A 3-Year Naturalistic Study of 53 Preschool Children With Pervasive Developmental Disorders Treated With Risperidone

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia: A Placebo-Controlled 26-Week Study

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder: A Preliminary Double-Blind, Placebo-Controlled Study

Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression

Incidence of Tardive Dyskinesia in First-Episode Psychosis Patients Treated With Low-Dose Haloperidol

Treatment of Previously Undiagnosed Psychiatric Disorders in Persons With Developmental Disabilities Decreased or Eliminated Self-Injurious Behavior

How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial?

Suicidal Ideation and Attempts Among Psychiatric Patients With Major Depressive Disorder

Psychoeducation Efficacy in Bipolar Disorders: Beyond Compliance Enhancement

The Use of Atypical Antipsychotics in Nursing Homes

Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine

Academic Highlights

Reducing the Risk for Suicide in Schizophrenia and Affective Disorders.

Letter to the Editor

Underdiagnosis of Bipolar II Disorders in the Community

Charles Bonnet Syndrome With Visual Hallucinations of Childhood Experience: Successful Treatment of 1 Patient With Risperidone

Polypharmacy in Schizophrenia: A Fuzzy Concept

Reply to Polypharmacy in Schizophrenia: A Fuzzy Concept

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

Book Review

Core Competencies for Psychiatric Practice: What Clinicians Need to Know ( A Report of the American Board of Psychiatry and Neurology)

Infanticide: Psychosocial and Legal Perspectives on Mothers Who Kill

Outcomes in Neurodevelopment and Genetic Disorders

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles